Ascendis Pharma A/S (asnd 2.25 04/01/28)
13F holders, Q4 2025 (December 31)7holders +3
4new positions
1sold out
$2.98avg. 13F price*
At the end of Q4 2025, 7 institutions reported holding Ascendis Pharma A/S (asnd 2.25 04/01/28) in their 13F filings, up 3 from Q3 2025. 4 opened new positions and 1 sold out. The largest holders were Boussard & Gavaudan Investment Management LLP ($12.0M), Polar Capital Holdings Plc ($7.1M) and State of Wisconsin Investment Board ($4.3M).
- Company
- Ascendis Pharma A/S (asnd 2.25 04/01/28)
- CUSIP
- 04351PAD3
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $23.1M |
| Exits | 1 | $46.5M |
All 13F filers, Q3 2025 → Q4 2025: 5,026,377 shares bought and 311,600 shares sold, net +4,714,777 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Boussard & Gavaudan Investment Management LLP | 1.81% | New | 8,500 | $12.0M |
| Polar Capital Holdings Plc | 0.03% | New | 5,000,000 | $7.1M |
| State of Wisconsin Investment Board | 0.01% | No change | 3,000,000 | $4.3M |
| Loomis Sayles & Co. L P | 0.00% | New | 17,716 | $3.8M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | No change | 2,000,000 | $2.8M |
| Bank of New York Mellon Corp | 0.00% | Reduce -33.3% | 200,000 | $279K |
| Oddo BHF Asset Management Sas | 0.01% | New | 161 | $229K |
"% of holder's portfolio" is ASCENDIS PHARMA A/S (ASND 2.25 04/01/28)'s weight in each manager's 13F, not the share of Ascendis Pharma A/S (asnd 2.25 04/01/28) the manager owns.